These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 30649057)
21. Tuberculosis-related mortality in people living with HIV in Europe and Latin America: an international cohort study. Podlekareva DN; Efsen AM; Schultze A; Post FA; Skrahina AM; Panteleev A; Furrer H; Miller RF; Losso MH; Toibaro J; Miro JM; Vassilenko A; Girardi E; Bruyand M; Obel N; Lundgren JD; Mocroft A; Kirk O; Lancet HIV; 2016 Mar; 3(3):e120-31. PubMed ID: 26939735 [TBL] [Abstract][Full Text] [Related]
22. Evaluation of a point-of-care tuberculosis test-and-treat algorithm on early mortality in people with HIV accessing antiretroviral therapy (TB Fast Track study): study protocol for a cluster randomised controlled trial. Fielding KL; Charalambous S; Hoffmann CJ; Johnson S; Tlali M; Dorman SE; Vassall A; Churchyard GJ; Grant AD Trials; 2015 Mar; 16():125. PubMed ID: 25872501 [TBL] [Abstract][Full Text] [Related]
23. Higher Mortality Despite Early Antiretroviral Therapy in Human Immunodeficiency Virus and Hepatitis B Virus (HBV)-Coinfected Patients With High HBV Replication. Kouamé GM; Boyd A; Moh R; Badje A; Gabillard D; Ouattara E; Ntakpe JB; Emième A; Maylin S; Chekaraou MA; Eholié SP; Zoulim F; Lacombe K; Anglaret X; Danel C; Clin Infect Dis; 2018 Jan; 66(1):112-120. PubMed ID: 29020361 [TBL] [Abstract][Full Text] [Related]
24. Brief Report: Yield and Efficiency of Intensified Tuberculosis Case-Finding Algorithms in 2 High-Risk HIV Subgroups in Uganda. Semitala FC; Cattamanchi A; Andama A; Atuhumuza E; Katende J; Mwebe S; Asege L; Nakaye M; Kamya MR; Yoon C J Acquir Immune Defic Syndr; 2019 Dec; 82(4):416-420. PubMed ID: 31658185 [TBL] [Abstract][Full Text] [Related]
25. Multidisciplinary Point-of-Care Testing in South African Primary Health Care Clinics Accelerates HIV ART Initiation but Does Not Alter Retention in Care. Stevens WS; Gous NM; MacLeod WB; Long LC; Variava E; Martinson NA; Sanne I; Osih R; Scott LE J Acquir Immune Defic Syndr; 2017 Sep; 76(1):65-73. PubMed ID: 28542080 [TBL] [Abstract][Full Text] [Related]
26. Diagnostic and prognostic value of serum C-reactive protein for screening for HIV-associated tuberculosis. Lawn SD; Kerkhoff AD; Vogt M; Wood R Int J Tuberc Lung Dis; 2013 May; 17(5):636-43. PubMed ID: 23575330 [TBL] [Abstract][Full Text] [Related]
27. Early Initiation of ARV Therapy Among TB-HIV Patients in Indonesia Prolongs Survival Rates! Maemun S; Mariana N; Rusli A; Mahkota R; Purnama TB J Epidemiol Glob Health; 2020 Jun; 10(2):164-167. PubMed ID: 32538033 [TBL] [Abstract][Full Text] [Related]
28. Point-of-care CD4+ technology implementation in Free State, South Africa, was associated with improved patient health outcomes. Van Turha L; Maharaj K; Rose A; Boeke C; Peter TF; Vojnov L; Quevedo J; Tsibolane Y S Afr Med J; 2020 Jan; 110(2):126-131. PubMed ID: 32657683 [TBL] [Abstract][Full Text] [Related]
29. Effect of isoniazid preventive therapy on risk of death in west African, HIV-infected adults with high CD4 cell counts: long-term follow-up of the Temprano ANRS 12136 trial. Badje A; Moh R; Gabillard D; Guéhi C; Kabran M; Ntakpé JB; Carrou JL; Kouame GM; Ouattara E; Messou E; Anzian A; Minga A; Gnokoro J; Gouesse P; Emieme A; Toni TD; Rabe C; Sidibé B; Nzunetu G; Dohoun L; Yao A; Kamagate S; Amon S; Kouame AB; Koua A; Kouamé E; Daligou M; Hawerlander D; Ackoundzé S; Koule S; Séri J; Ani A; Dembélé F; Koné F; Oyebi M; Mbakop N; Makaila O; Babatunde C; Babatunde N; Bleoué G; Tchoutedjem M; Kouadio AC; Sena G; Yededji SY; Karcher S; Rouzioux C; Kouame A; Assi R; Bakayoko A; Domoua SK; Deschamps N; Aka K; N'Dri-Yoman T; Salamon R; Journot V; Ahibo H; Ouassa T; Menan H; Inwoley A; Danel C; Eholié SP; Anglaret X; Lancet Glob Health; 2017 Nov; 5(11):e1080-e1089. PubMed ID: 29025631 [TBL] [Abstract][Full Text] [Related]
30. Predicting death and lost to follow-up among adults initiating antiretroviral therapy in resource-limited settings: Derivation and external validation of a risk score in Haiti. McNairy ML; Jannat-Khah D; Pape JW; Marcelin A; Joseph P; Mathon JE; Koenig S; Wells M; Fitzgerald DW; Evans A PLoS One; 2018; 13(8):e0201945. PubMed ID: 30157197 [TBL] [Abstract][Full Text] [Related]
31. Characteristics and outcomes of adult Ethiopian patients enrolled in HIV care and treatment: a multi-clinic observational study. Melaku Z; Lamb MR; Wang C; Lulseged S; Gadisa T; Ahmed S; Habtamu Z; Alemu H; Assefa T; Abrams EJ BMC Public Health; 2015 May; 15():462. PubMed ID: 25934178 [TBL] [Abstract][Full Text] [Related]
32. Baseline factors associated with mortality within six months after admission among hospitalized HIV-1 patients in Shenyang, China. Wen Y; Zhou Y; Wang W; Wang Y; Lu X; Sun CM; Cui W; Liu J; Geng WQ; Shang H; Liu P Intern Med; 2014; 53(21):2455-61. PubMed ID: 25366003 [TBL] [Abstract][Full Text] [Related]
33. Hyponatremia, hypochloremia, and hypoalbuminemia predict an increased risk of mortality during the first year of antiretroviral therapy among HIV-infected Zambian and Kenyan women. Dao CN; Peters PJ; Kiarie JN; Zulu I; Muiruri P; Ong'ech J; Mutsotso W; Potter D; Njobvu L; Stringer JS; Borkowf CB; Bolu O; Weidle PJ AIDS Res Hum Retroviruses; 2011 Nov; 27(11):1149-55. PubMed ID: 21417949 [TBL] [Abstract][Full Text] [Related]
34. Barriers to Care and 1-Year Mortality Among Newly Diagnosed HIV-Infected People in Durban, South Africa. Bassett IV; Coleman SM; Giddy J; Bogart LM; Chaisson CE; Ross D; Flash MJ; Govender T; Walensky RP; Freedberg KA; Losina E J Acquir Immune Defic Syndr; 2017 Apr; 74(4):432-438. PubMed ID: 28060226 [TBL] [Abstract][Full Text] [Related]
35. Six-month mortality among HIV-infected adults presenting for antiretroviral therapy with unexplained weight loss, chronic fever or chronic diarrhea in Malawi. van Lettow M; Åkesson A; Martiniuk AL; Ramsay A; Chan AK; Anderson ST; Harries AD; Corbett E; Heyderman RS; Zachariah R; Bedell RA PLoS One; 2012; 7(11):e48856. PubMed ID: 23185278 [TBL] [Abstract][Full Text] [Related]
36. Predictors of Mortality among Tuberculosis/HIV-Coinfected Persons in Southwest Ethiopia: A Case-Control Study. Deribe K; Yami A; Deribew A; Mesfin N; Colebunders R; Van Geertruyden JP; Woldie M; Maja T J Int Assoc Provid AIDS Care; 2015; 14(3):269-73. PubMed ID: 23966102 [TBL] [Abstract][Full Text] [Related]
37. Incidence and mortality of tuberculosis before and after initiation of antiretroviral therapy: an HIV cohort study in India. Alvarez-Uria G; Pakam R; Midde M; Naik PK J Int AIDS Soc; 2014; 17(1):19251. PubMed ID: 25499123 [TBL] [Abstract][Full Text] [Related]
38. Predictors of mortality within the first year of initiating antiretroviral therapy in urban and rural Kenya: A prospective cohort study. Silverman RA; John-Stewart GC; Beck IA; Milne R; Kiptinness C; McGrath CJ; Richardson BA; Chohan B; Sakr SR; Frenkel LM; Chung MH PLoS One; 2019; 14(10):e0223411. PubMed ID: 31584992 [TBL] [Abstract][Full Text] [Related]
39. Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome after early initiation of antiretroviral therapy in a randomized clinical trial. Laureillard D; Marcy O; Madec Y; Chea S; Chan S; Borand L; Fernandez M; Prak N; Kim C; Dim B; Nerrienet E; Sok T; Delfraissy JF; Goldfeld AE; Blanc FX; AIDS; 2013 Oct; 27(16):2577-86. PubMed ID: 24096631 [TBL] [Abstract][Full Text] [Related]
40. Retention and mortality outcomes from a community-supported public-private HIV treatment programme in Myanmar. Mburu G; Paing AZ; Myint NN; Di W; Thu KH; Ram M; Hoffmann CJ; Wang B; Naing S J Int AIDS Soc; 2016; 19(1):20926. PubMed ID: 27784509 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]